Post-transcriptional regulation of cytokine signaling by AU-rich and GU-rich elements

Journal of Interferon and Cytokine Research

Volumn 34, Issue 4, 2014, Pages 233-241

  Vlasova St Louis, Irina ^a,b   Bohjanen, Paul R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; HU ANTIGEN; INTERFERON; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; RIBONUCLEASE L; RNA BINDING PROTEIN; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; GUANINE;

3' UNTRANSLATED REGION; ANGIOGENESIS; AU RICH ELEMENT; CELL FUNCTION; CELL MIGRATION; CELL STRESS; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE CONTROL; GENE EXPRESSION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL COMMUNICATION; CELL GROWTH; GENE EXPRESSION REGULATION; GENETICS; IMMUNITY; IMMUNOLOGY; METABOLISM; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; AU RICH ELEMENTS; CELL COMMUNICATION; CELL GROWTH PROCESSES; CYTOKINES; GENE EXPRESSION REGULATION; GUANINE; HUMANS; IMMUNITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84898712109     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0108     Document Type: Review

References (68)

1. Abdelmohsen K, Lal A, Kim HH, Gorospe M. 2007. Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6(11):1288-1292.
2. Al-Haj L, Khabar KS. 2012. Cloning of cytokine 3¢ untranslated regions and posttranscriptional assessment using cell-based GFP assay. Methods Mol Biol 820:91-104.
3. Anderson P. 2008. Post-transcriptional control of cytokine production. Nat Immunol 9(4):353-359.
4. Anderson P. 2010. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10(1):24-35.
5. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS. 2001.ARED: Human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29(1):246-254.
6. Bakheet T, Williams BR, Khabar KS. 2006. ARED 3.0: The large and diverse AU-rich transcriptome. Nucleic Acids Res 34(Database issue):D111-D114.
7. Beisang D, Bohjanen P, Vlasova-St. Louis I. 2012a. CELF1, a multifunctional regulator of posttranscriptional networks. In: Abdelmohsen K, ed. Binding protein, Chapter 8. In-Tech(Open Access). DOI: 10.5772/48780, pp 181-206.
8. Beisang D, Bohjanen PR. 2012. Perspectives on the ARE as it turns 25 years old. Wiley Interdiscip Rev RNA 3(5): 719-731.
9. Beisang D, Rattenbacher B, Vlasova-St. Louis IA, Bohjanen PR. 2012b. Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation. J Biol Chem 287(2):950-960.
10. Bronicki LM, Jasmin BJ. 2013. Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA 19(8):1019-1037.
11. Brooks SA, Blackshear PJ. 2013. Tristetraprolin (TTP): Interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim Biophys Acta 1829(6-7): 666-679.
12. Candido J, Hagemann T. 2013. Cancer-related inflammation. J Clin Immunol 33(Suppl 1):S79-S84.
13. Chen CY, Shyu AB. 1995. AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem Sci 20(11):465-470.
14. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. 2001. The 3¢ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21(3):721-730.
15. Duan J, Shi J, Ge X, Dolken L, Moy W, He D, Shi S, Sanders AR, Ross J, Gejman PV. 2013. Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci Rep 3:1318.
16. Emmons J, Townley-Tilson WH, Deleault KM, Skinner SJ, Gross RH, Whitfield ML, Brooks SA. 2008. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14(5): 888-902.
17. Fan J, Ishmael FT, Fang X, Myers A, Cheadle C, Huang SK, Atasoy U, Gorospe M, Stellato C. 2011. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol 186(4):2482-2494.
18. Frasca D, Romero M, Landin AM, Diaz A, Riley RL, Blomberg BB. 2010. Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability. Mech Ageing Dev 131(5):306-314.
19. Friedel CC, Dolken L, Ruzsics Z, Koszinowski UH, Zimmer R. 2009. Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res 37(17):e115.
20. Fuxe J, Karlsson MC. 2012. TGF-beta-induced epithelialmesenchymal transition: A link between cancer and inflammation. Semin Cancer Biol 22(5-6):455-461.
21. Gratacos FM, Brewer G. 2010. The role of AUF1 in regulated mRNA decay. Wiley Interdiscip Rev RNA 1(3):457-473.
22. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835-840.
23. Halees AS, El-Badrawi R, Khabar KS. 2008. ARED organism: Expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res 36(Database issue):D137-D140.
24. Halees AS, Hitti E, Al-Saif M, Mahmoud L, Vlasova-St. Louis IA, Beisang DJ, Bohjanen PR, Khabar K. 2011. Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol 8(4):681-691.
25. Hao S, Baltimore D. 2009. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10(3):281-288.
26. Ivanov P, Anderson P. 2013. Post-transcriptional regulatory networks in immunity. Immunol Rev 253(1):253-272.
27. Janga SC, Mittal N. 2011. Construction, structure and dynamics of post-transcriptional regulatory network directed by RNAbinding proteins. Adv Exp Med Biol 722:103-117.
28. Keene JD. 2007. RNA regulons: Coordination of posttranscriptional events. Nat Rev Genet 8(7):533-543.
29. Khabar KS. 2007. Rapid transit in the immune cells: The role of mRNA turnover regulation. J Leukoc Biol 81(6):1335-1344.
30. Khabar KS. 2010. Post-transcriptional control during chronic inflammation and cancer: A focus on AU-rich elements. Cell Mol Life Sci 67(17):2937-2955.
31. Khabar KS, Young HA. 2007. Post-transcriptional control of the interferon system. Biochimie 89(6-7):761-769.
32. Lee JE, Lee JY, Wilusz J, Tian B, Wilusz CJ. 2010. Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One 5(6):e11201.
33. Li X, LinWJ, Chen CY, Si Y, Zhang X, Lu L, Suswam E, Zheng L, King PH. 2012. KSRP: A checkpoint for inflammatory cytokine production in astrocytes. Glia 60(11):1773-1784.
34. Liao W, Lin JX, Leonard WJ. 2011. IL-2 family cytokines: New insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23(5): 598-604.
35. Linossi EM, Babon JJ, Hilton DJ, Nicholson SE. 2013. Suppression of cytokine signaling: The SOCS perspective. Cytokine Growth Factor Rev 24(3):241-248.
36. Lopez de Silanes I, Galban S, Martindale JL, Yang X, Mazan-Mamczarz K, Indig FE, Falco G, Zhan M, Gorospe M. 2005. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol 25(21): 9520-9531.
37. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. 2004. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101(9):2987-2992.
38. Mansfield KD, Keene JD. 2009. The ribonome: A dominant force in co-ordinating gene expression. Biol Cell 101(3):169-181.
39. Moore AE, Young LE, Dixon DA. 2011. MicroRNA and AUrich element regulation of prostaglandin synthesis. Cancer Metastasis Rev 30(3-4):419-435.
40. Moudgil KD, Choubey D. 2011. Cytokines in autoimmunity: Role in induction, regulation, and treatment. J Interferon Cytokine Res 31(10):695-703.
41. Mukherjee N, Lager PJ, Friedersdorf MB, Thompson MA, Keene JD. 2009. Coordinated posttranscriptional mRNA population dynamics during T-cell activation. Mol Syst Biol 5:288.
42. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL. 2012. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res 91(7):651-658.
43. Raghavan A, Dhalla M, Bakheet T, Ogilvie RL, Vlasova IA, Khabar KS, Williams BR, Bohjanen PR. 2004. Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation. Genomics 84(6):1002-1013.
44. Raghavan A, Robison RL, McNabb J, Miller CR, Williams DA, Bohjanen PR. 2001. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem 276(51): 47958-47965.
45. Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, St. Louis-Vlasova IA, Bohjanen PR. 2010. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 30(16):3970-3980.
46. Ronkina N, Menon MB, Schwermann J, Tiedje C, Hitti E, Kotlyarov A, Gaestel M. 2010. MAPKAP kinases MK2 and MK3 in inflammation: Complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Biochem Pharmacol 80(12):1915-1920.
47. Schott J, Stoecklin G. 2010. Networks controlling mRNA decay in the immune system. Wiley Interdiscip Rev RNA 1(3): 432-456.
48. Seko Y, Cole S, Kasprzak W, Shapiro BA, Ragheb JA. 2006. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev 5(5):299-305.
49. Srikantan S, Gorospe M. 2012. HuR function in disease. Front Biosci 17:189-205.
50. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283(17):11689-11699.
51. Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Chung YJ, Shelley WC, Richfield EK, Ray MK, Yoder MC, Aplan PD, Blackshear PJ. 2009. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 114(12): 2401-2410.
52. Stumpo DJ, Lai WS, Blackshear PJ. 2010. Inflammation: Cytokines and RNA-based regulation. Wiley Interdiscip Rev RNA 1(1):60-80.
53. Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP. 2007. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 282(6):3766-3777.
54. Talwar S, Balasubramanian S, Sundaramurthy S, House R, Wilusz CJ, Kuppuswamy D, D'Silva N, Gillespie MB, Hill EG, Palanisamy V. 2013. Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes proapoptotic mRNAs in oral cancer cells. RNA Biol 10(2):277-286.
55. Turner M, Hodson D. 2012a. Regulation of lymphocyte development and function by RNA-binding proteins. Curr Opin Immunol 24(2):160-165.
56. Turner M, Hodson DJ. 2012b. An emerging role of RNAbinding proteins as multifunctional regulators of lymphocyte development and function. Adv Immunol 115:161-185.
57. Vacchelli E, Galluzzi L, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G. 2012. Trial Watch: Immunostimulatory cytokines. Oncoimmunology 1(4):493-506.
58. van Kouwenhove M, Kedde M, Agami R. 2011. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11(9):644-656.
59. Vlasova IA, Bohjanen PR. 2008. Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins. RNA Biol 5(4):201-207.
60. Vlasova IA, McNabb J, Raghavan A, Reilly C, Williams DA, Bohjanen KA, Bohjanen PR. 2005. Coordinate stabilization of growth-regulatory transcripts in T cell malignancies. Genomics 86(2):159-171.
61. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, Sternjohn JR, Vasdewani J, Karypis G, Reilly CS, Bitterman PB, Bohjanen PR. 2008. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 29(2):263-270.
62. Vlasova-St. Louis I, Bohjanen PR. 2011. Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1. Curr Opin Genet Dev 21(4):444-451.
63. Vlasova-St. Louis I, Dickson AM, Bohjanen PR, Wilusz CJ. 2013. CELFish ways to modulate mRNA decay. Biochim Biophys Acta 1829(6-7):695-707.
64. von Roretz C, Di Marco S, Mazroui R, Gallouzi IE. 2011. Turnover of AU-rich-containing mRNAs during stress: A matter of survival. Wiley Interdiscip Rev RNA 2(3):336-347.
65. Whelan JT, Hollis SE, Cha DS, Asch AS, Lee MH. 2012. Posttranscriptional regulation of the Ras-ERK/MAPK signaling pathway. J Cell Physiol 227(3):1235-1241.
66. Winzen R, Thakur BK, Dittrich-Breiholz O, Shah M, Redich N, Dhamija S, Kracht M, Holtmann H. 2007. Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets. Mol Cell Biol 27(23):8388-8400.
67. Wu X, Chesoni S, Rondeau G, Tempesta C, Patel R, Charles S, Daginawala N, Zucconi BE, Kishor A, Xu G, Shi Y, Li ML, Irizarry-Barreto P, Welsh J, Wilson GM, Brewer G. 2013. Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs. Nucleic Acids Res 41(4):2644-2658.
68. Zhang L, Lee JE, Wilusz J, Wilusz CJ. 2008. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: Implications for myotonic dystrophy. J Biol Chem 283:22457-22463.